Tucaxen 150mg Tablets (Tucatinib)

Tucaxen 150mg contains Tucatinib, a targeted therapy that blocks HER2 signaling involved in the growth and spread of certain cancer cells. It is used in combination with other medicines for specific advanced or metastatic cancers.

Key Information

• Active Ingredient: Tucatinib
• Strength: 150mg
• Manufacturer: Everest Pharmaceuticals Ltd.
• Form: Oral tablets
• Quantity: 30 tablets per box
• Uses: Used with other treatments for HER2-positive metastatic breast cancer, including disease that has spread to the brain, and certain HER2-positive advanced colorectal cancers.
• Common Side Effects: Diarrhea, nausea, vomiting, fatigue, rash, mouth sores, decreased appetite, headache and anemia may occur.
• Important: Tucatinib can affect liver function and may cause severe diarrhea. Regular medical monitoring may be required during treatment.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare professional before starting or changing any medication.